/5
0 avis
Pre-Emptive Rituximab Treatment for Epstein\textendashBarr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation Is a Worthwhile Strategy in High-Risk Recipients: A Comparative Study for Immune Recovery and Clinical Outcomes
Archive ouverte
Edité par CCSD ; Nature Publishing Group -
International audience
Consulter en ligne
Chargement des enrichissements...